# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-050088
Filing Date
2024-04-30
Accepted
2024-04-29 18:10:30
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | inkt-ars-2023.pdf | ARS | 942555
| Complete submission text file | 0000950170-24-050088.txt |  | 1299597

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40908 | Film No.: 24893255
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)